Evidence base GLP-1 medications have extensive randomised controlled trial data demonstrating cardiovascular and renal benefits in addition to glycaemic control
The study observed that a blood marker known as -hydroxybutyrate increased in those receiving four milligrams or more at 24 weeks and in the 12 milligram group at 48 weeks
It applies your dietary filters first (vegetarian, vegan, dairy-free, or gluten-free), then scores remaining recipes based on your GLP-1 preferences: high protein content, nausea-friendly ingredients, and cooking time
And so Exenatide, which is kind of the OG, thats millions of prescriptions have been written
These medications are not intended as a shortcut
For people transitioning specifically because of metabolic health concerns beyond weight, this distinction matters enormously